Pharmacokinetic Evaluation of Intranasal Nalmefene

Clinical trial NCT04759768 · COMPLETED

Trial details

NCT number: NCT04759768
Sponsor: Opiant Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2021-02-08
Primary completion: 2021-05-17
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.